Hajdu-Cheney syndrome is a rare, autosomal dominant skeletal dysplasia marked by acro-osteolysis of the distal phalanges and severe osteoporosis. Although there are more than 60 reports published to date, proper treatment and subsequent outcome have been scarce. Herein, we report a progress of anti-resorptive therapy with zoledronic acid, in a woman with Hajdu-Cheney syndrome. Results suggest that anti-resorptive therapy may be important in delaying the progress of osteoporosis and preventing fractures, but not necessarily acro-osteolysis itself.
Effect of Zoledronic Acid on Acro-Osteolysis and Osteoporosis in a Patient with Hajdu-Cheney Syndrome
Sena Hwang,Dong Yeob Shin,S. Moon,Eun Jig Lee,Sungkil Lim,O. Kim,Y. Rhee
Published 2011 in Yonsei medical journal
ABSTRACT
PUBLICATION RECORD
- Publication year
2011
- Venue
Yonsei medical journal
- Publication date
2011-04-06
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-19 of 19 references · Page 1 of 1
CITED BY
Showing 1-25 of 25 citing papers · Page 1 of 1